Olanzapin - zuverlässig in allen Therapiephasen - In der Akutphase die erfolgreiche Langzeittherapie einleiten

doi:10.1055/s-2005-922796

psychoneuro, Table of Contents

psychoneuro 2005; 31(11): 549-550
DOI: 10.1055/s-2005-922796

Schizophrenietherapie - Erfolg in allen Phasen

Olanzapin - zuverlässig in allen Therapiephasen - In der Akutphase die erfolgreiche Langzeittherapie einleiten

Abstract

Full Text

References

Literatur

13 Beasley CM . et al . A Double-Blind, Randomized, Placebo-Controlled Trial of Olanzapine in the Prevention of Psychotic Relapse. J Clin Psychopharmacology. 2003; 23(6) 582-594
14 Cañas F . et al . Safety, Effectiveness, and Patterns of Use of Olanzapine in Acute Schizophrenia: A Multivariate Analysis of a Large Naturalistic Study in the Hospital Setting. Med Clin (Barc). 2005; 124(13) 481-6
15 Czekalla J . et al . Improvement of Suicidal Ideation and Medication Acceptance under Treatment with Olanzapine Disintegrating and Coated Olanzapine Tablets. Results from a Prospective Multi-Center Study of Acutely Ill Psychiatric Inpatients. Schizophr Res. 2004; 67(Suppl 1) 214
16 Expert Group: . "Schizophrenia and Diabetes 2003" Expert Consensus Meeting, Dublin, 3-4 October 2003: consensus summary. British Journal of Psychiatry. 2004; 184(suppl. 47) s112-4
17 Haro JM . et al . Antipsychotic Treatment Discontinuation in the Outpatient Treatment for Schizophrenia. 24-Months Results of the Paneuropean SOHO Study. Schizophr Bull. 2005; 31(2) 486
18 Keefe RSE . et al . Comparative Effect of Atypical and Conventional Antipsychotic Drugs on Neurocognition in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Low Doses of Haloperidol. Am J Psychiatry. 2004; 161 98595
19 Kinon B.J . et al . Zyprexa® VeloTab^TM bei der Behandlung nicht komplianter Schizophrenie-Patienten im Akutstadium, American Psychiatric Association (APA); 2001.
20 Littrell KH . et al . The Effects of an Educational Intervention on Antipsychotic-Induced Weight Gain. Journal of Nursing Scholarship. 2003; 35(3) 237-241
21 Liu-Seifert H . et al . Discontinuation from Schizophrenia Treatment is Driven by Poor Symptom Response. A Post-Hoc Analysis of 4 Atypical Antipsychotics Combined. Posterpräsentation beim International Congress on Schizophrenia Research 2005, 2.-6. April 2005, Savannah GA.
22 Möller H-J . Antidepressive Effects of Traditional and Second Generation Antipsychotics. A Review of the Clinical Data. Eur Arch Psychiatry Clin Neurosci. 2005; 255 83-93
23 Olivares JM . et al . Olanzapine versus Risperidone: One-Year Results in Social Functioning in Schizophrenia. Posterpräsentation beim Kongress der American Psychiatric Association 2005, 1.-6. Mai 2004; New York, USA.
24 Robinson D . et al . Predictors of Relapse Following Response from a First Episode of Schizophrenia or Schizoaffective Disorder. Arch Gen Psychiatry. 1999; 56(3) 241-7